Triage Survey for Psychiatry Research Eligibility

Recruiting

• Conditions: Generalized Anxiety Disorder; Major Depressive Disorder; Borderline Personality Disorder

• Registration Number: NCT05800925
• Lead Sponsor: Adams Clinical

Brief Summary

TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-21
• Study First Submitted: 2023-03-24
• Study First Submitted QC: 2023-03-24
• Study First Posted: 2023-04-06
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-19
• Last Update Posted: 2023-10-23
• Primary Completion: 2025-12-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
• Participant is at least 18 years old.

Exclusion Criteria

• Participant is pregnant, breast-feeding, or planning to become pregnant.
• History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
• Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
• Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
• Any condition that in the investigator's opinion makes a participant unsuitable for the study.
• Currently employed by Adams Clinical or a first-degree relative of an employee.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study	Up to 52 weeks

Secondary Outcome Measures

Name	Time	Method
The proportion of participants who enroll in industry-sponsored clinical trials	Up to 52 weeks
The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials	Up to 52 weeks

Trial Locations

Locations (3)

Adams Clinical; 🇺🇸 Watertown, Massachusetts, United States

Copley Clinical; 🇺🇸 Boston, Massachusetts, United States

Berman Clinical; 🇺🇸 New York, New York, United States